These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1260169)

  • 1. The effects of intra-amygdaloid injections of 6-hydroxy-dopamine on avoidance responding in rats.
    Ashford J; Jones BJ
    Br J Pharmacol; 1976 Mar; 56(3):255-61. PubMed ID: 1260169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of dorsal bundle injections of 6-hydroxydopamine on avoidance responding in rats.
    Fibiger HC; Mason ST
    Br J Pharmacol; 1978 Dec; 64(4):601-5. PubMed ID: 728687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of the intracisternal administration of the neurotoxins 6-hydroxydopamine and 5,7-dihydroxytryptamine on the formation of the passive avoidance reaction and the biogenic amine level in the brain of rats].
    Shabanov PD; Bul'on VV; Lénárd L
    Fiziol Zh SSSR Im I M Sechenova; 1988 Jul; 74(7):920-3. PubMed ID: 3141223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of brain noradrenaline and the pituitary-adrenal axis in learning and extinction.
    Mason ST; Roberts DC; Fibiger HC
    Pharmacol Biochem Behav; 1979 Jan; 10(1):11-6. PubMed ID: 441087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of active avoidance of responding after lateral hypothalamic injections of 6-hydroxydopamine.
    Smith GP; Levin BE; Ervin GN
    Brain Res; 1975 May; 88(3):483-98. PubMed ID: 1139290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of avoidance deficits produced by 6-hydroxydopamine lesions of the nigrostriatal system of the rat.
    Delacour J; Echavarria MT; Senault B; Houcine O
    J Comp Physiol Psychol; 1977 Aug; 91(4):875-85. PubMed ID: 893749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminated escape learning and response to electric shock after 6-hydroxydopamine lesions of the nigro-neostriatal dopaminergic projection.
    Price MT; Fibiger HC
    Pharmacol Biochem Behav; 1975; 3(2):285-90. PubMed ID: 1096176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraventricular 6-hydroxydopamine in the newborn rat and locomotor responses to drugs in infancy: no support for the dopamine depletion model of minimal brain dysfunction.
    Pappas BA; Gallivan JV; Dugas T; Saari M; Ings R
    Psychopharmacology (Berl); 1980; 70(1):41-6. PubMed ID: 6775333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal 6-hydroxydopamine-induced dopamine depletions: motor activity and performance in maze learning.
    Archer T; Danysz W; Fredriksson A; Jonsson G; Luthman J; Sundström E; Teiling A
    Pharmacol Biochem Behav; 1988 Oct; 31(2):357-64. PubMed ID: 3149743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects on homeostasis of intraventricular injections of 6-hydroxydopamine in rats.
    Stricker EM; Zigmond MJ
    J Comp Physiol Psychol; 1974 Jun; 86(6):973-94. PubMed ID: 4836848
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of apomorphine on escape performance and activity in developing rat pups treated with 6-hydroxydopamine (6-OHDA).
    Lipton SV; McGough JP; Shaywitz BA
    Pharmacol Biochem Behav; 1980 Sep; 13(3):371-7. PubMed ID: 7191569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-Hydroxydopamine induced catecholamine depletion and passive avoidance learning in rats.
    Oei TP; Ng CP
    Pharmacol Biochem Behav; 1978 May; 8(5):553-6. PubMed ID: 674261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intra-amygdala injections of NMDA receptor antagonists on acquisition and retention of inhibitory avoidance.
    Kim M; McGaugh JL
    Brain Res; 1992 Jul; 585(1-2):35-48. PubMed ID: 1387340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine.
    Cooper BR; Breese GR; Grant LD; Howard JL
    J Pharmacol Exp Ther; 1973 May; 185(2):358-70. PubMed ID: 4703827
    [No Abstract]   [Full Text] [Related]  

  • 15. 3-methoxy-4-hydroxyphenylglycol excretion and behavioural changes in rat and monkey after central sympathecomy with 6-hydroxydopamine.
    Breese GR; Prange AJ; Howard JL; Lipton MA; McKinney WT; Bowman RE; Bushnell P
    Nat New Biol; 1972 Dec; 240(104):286-7. PubMed ID: 4633263
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of central catecholamine alterations by 6-hydroxydopamine on shuttle box avoidance acquistion.
    Cooper BR; Breese GR; Howard JL; Grant LD
    Physiol Behav; 1972; 9(5):727-31. PubMed ID: 4655165
    [No Abstract]   [Full Text] [Related]  

  • 17. 6-OHDA lesion of the dorsal noradrenergic bundle alters extinction of passive avoidance.
    Mason ST; Fibiger HC
    Brain Res; 1978 Aug; 152(1):209-14. PubMed ID: 679025
    [No Abstract]   [Full Text] [Related]  

  • 18. [Specificity of the effect on the avoidance conditionning of microinjections of 6-hydroxydopamine in rat nigro-striatal system].
    Echavarria-Mage MT; Senault B; Delacour J
    C R Acad Hebd Seances Acad Sci D; 1976 Mar; 282(9):905-7. PubMed ID: 820478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of brain levels of norepinephrine and dopamine to avoidance behavior in rats after intraventricular administration of 6-hydoxydopamine.
    Lenard LG; Beer B
    Pharmacol Biochem Behav; 1975; 3(5):895-9. PubMed ID: 1208632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Action of 6-hydroxydopamine on two parameters of motor learning.
    Derevenco P; Baciu I; Stoica N; Sovrea I; Vitebski V; Vaida A; Zdrenghea V
    Physiologie; 1980; 17(3):211-5. PubMed ID: 6779294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.